5 Key Takeaways

• 1

  Suprachoroidal triamcinolone acetonide is effective for treating macular edema associated with uveitis in real-world settings.

• 2

  The study analyzed data from 785 patients, revealing that a single injection provides durable relief from uveitic macular edema.

• 3

  Patients with a history of glaucoma or ocular hypertension can safely use suprachoroidal triamcinolone acetonide with manageable IOP increases.

• 4

  The incidence of significant IOP elevations is low, making this treatment a viable option for at-risk patients.

• 5

  Regular follow-up is recommended to monitor IOP changes after treatment with suprachoroidal triamcinolone acetonide.